Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies

Código QR

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies

Aim. To study the significance of clinical and laboratory non-invasive indexes along with the insulin resistance index when carrying out diagnostic assessment of non-alcoholic fatty liver disease (NAFLD) during screening examinations. Materials and methods. The study involved 348 employees workin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aleksandr E. Nosov, Mariia T. Zenina, Olga Y. Gorbushina, Anastasiia S. Baidina, Elena M. Vlasova, Vadim B. Alekseev
Formato:	article
Lenguaje:	RU
Publicado:	"Consilium Medicum" Publishing house 2021
Materias:	non-alcoholic fatty liver disease ultrasound scanning of the liver insulin resistance steatosis indexes Medicine R
Acceso en línea:	https://doaj.org/article/3cee5aaa82a146e1aca7ea4069fc4b81
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
por: N. V. Mikhaylova, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
por: Tetiana Ranhulova
Publicado: (2021)

Cytoprotective and suicidal signaling in oxidative stress
por: Videla,Luis A
Publicado: (2010)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
por: Pegah Golabi, et al.
Publicado: (2022)

Biochemical assessment of metabolic associated fatty liver disease
por: Guerra-Ruiz Armando R., et al.
Publicado: (2021)

Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice
por: Li L, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
por: Sue Shea, et al.
Publicado: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
por: Chen L, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
por: Cosmas Rinaldi Adithya Lesmana, et al.
Publicado: (2019)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
por: Aleksandr I. Pavlov, et al.
Publicado: (2021)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Satoru Hagiwara, et al.
Publicado: (2021)

Alteraciones de la tolerancia a la glucosa y frecuencia de síndrome metabólico en pacientes con enfermedad por hígado graso no alcohólico
por: Araya Q,A. Verónica, et al.
Publicado: (2006)

DHA Protects Against Hepatic Steatosis by Activating Sirt1 in a High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model
por: Luo X, et al.
Publicado: (2020)

Correlation Between COVID-19 Severity, Body Mass Index and Radiological Hepatic Morphology
por: Qandeel,Haitham, et al.
Publicado: (2021)

Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development
por: Junli Liu, et al.
Publicado: (2021)

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions
por: Gharaibeh NE, et al.
Publicado: (2019)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
por: Hao Xu, et al.
Publicado: (2021)

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study
por: Rayvita AN Meagratia, et al.
Publicado: (2021)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani D, et al.
Publicado: (2020)

Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
por: Shida T, et al.
Publicado: (2019)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
por: Zhai M, et al.
Publicado: (2021)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
por: Evgenia Pavlovna Kosobyan, et al.
Publicado: (2010)

Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease
por: Abdulrahman Ismaiel, et al.
Publicado: (2021)

Non-invasive Diagnostics of Liver Fibrosis
por: Mihaylov R., et al.
Publicado: (2017)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
por: Lauszus JS, et al.
Publicado: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Daniela Maria Tanase, et al.
Publicado: (2021)

Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
por: Parvanescu T, et al.
Publicado: (2021)

Reduced steatosis and weight as a result of specific diets or the dietitian themselves
por: Hirsh D. Trivedi, et al.
Publicado: (2021)

Rol de la microbiota intestinal en el desarrollo del hígado graso no alcohólico
por: Tumani,María Fernanda, et al.
Publicado: (2021)

Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
por: Lanuza,Fabian, et al.
Publicado: (2018)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Siyu Yu, et al.
Publicado: (2021)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
por: Zhi-Qin Xie, et al.
Publicado: (2021)

Hepatic Response of Magnesium-Restricted Wild Type Mice
por: Vera H. Fengler, et al.
Publicado: (2021)

Association of insulin resistance and non-alcoholic fatty liver disease
por: Ekaterina E. Mishina, et al.
Publicado: (2021)

Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice
por: Jian-Lin Lai, et al.
Publicado: (2021)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
por: Alswat K, et al.
Publicado: (2021)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
por: Ana Šinkovec, et al.
Publicado: (2021)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)